最新报道:Semler Scientific, a Nasdaq-listed medical device company, has purchased 581 BTC for $50 million, including fees, as part of its treasury strategy. The firm's CEO, Doug Murphy-Chutorian, stated that Bitcoin is a "reasonable hedge against inflation" and offers long-term growth potential. Semler joins other public companies like MicroStrategy in holding BTC as a reserve asset. The company may acquire more Bitcoin in the future, depending on market conditions. This move follows Semler's recent $17 million share buyback and reflects its confidence in Bitcoin's store-of-value proposition amid economic uncertainty.